We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01408160
Recruitment Status : Unknown
Verified January 2016 by Amit Verma, Albert Einstein College of Medicine of Yeshiva University.
Recruitment status was:  Recruiting
First Posted : August 3, 2011
Last Update Posted : January 15, 2016
Sponsor:
Collaborator:
Information provided by (Responsible Party):